title: Reply: High Risk of Gastrointestinal Bleeding on Dual Antiplatelet Treatment.
authors: Muthiah
authors: M
authors: Vaduganathan
authors: Deepak L
authors: DL
authors: Bhatt
authors: Byron L
authors: BL
authors: Cryer
authors: Yuyin
authors: Y
authors: Liu
authors: Wen-Hua
authors: WH
authors: Hsieh
authors: Gheorghe
authors: G
authors: Doros
authors: Marc
authors: M
authors: Cohen
authors: Angel
authors: A
authors: Lanas
authors: Thomas J
authors: TJ
authors: Schnitzer
authors: Thomas L
authors: TL
authors: Shook
authors: Pablo
authors: P
authors: Lapuerta
authors: Mark A
authors: MA
authors: Goldsmith
authors: Loren
authors: L
authors: Laine
authors: Christopher P
authors: CP
authors: Cannon
mesh_terms: D001241:Aspirin; D004359:Drug Therapy, Combination; D006471:Gastrointestinal Hemorrhage; D006801:Humans; D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine
chemical_list: D010975:Platelet Aggregation Inhibitors; D013988:Ticlopidine; D001241:Aspirin